Article
Schrödinger's in-house pipeline helps fetch $2.7B molecule discovery deal with BMS
Rating:
0.0
Views:
131
Likes:
1
Library:
1
Like AstraZeneca, Bayer and Sanofi before it, Bristol Myers Squibb has now tapped molecule modeler Schrödinger for a drug discovery collaboration spanning multiple disease areas.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value